Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP527882.RABShRb7SefYCxrajy81rCKMrfiXjxNesURfS_0NNcQ58130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP527882.RABShRb7SefYCxrajy81rCKMrfiXjxNesURfS_0NNcQ58130_assertion type Assertion NP527882.RABShRb7SefYCxrajy81rCKMrfiXjxNesURfS_0NNcQ58130_head.
- NP527882.RABShRb7SefYCxrajy81rCKMrfiXjxNesURfS_0NNcQ58130_assertion wasGeneratedBy ECO_0000203 NP527882.RABShRb7SefYCxrajy81rCKMrfiXjxNesURfS_0NNcQ58130_provenance.
- NP527882.RABShRb7SefYCxrajy81rCKMrfiXjxNesURfS_0NNcQ58130_assertion wasDerivedFrom befree-20150227 NP527882.RABShRb7SefYCxrajy81rCKMrfiXjxNesURfS_0NNcQ58130_provenance.
- NP527882.RABShRb7SefYCxrajy81rCKMrfiXjxNesURfS_0NNcQ58130_assertion SIO_000772 19358724 NP527882.RABShRb7SefYCxrajy81rCKMrfiXjxNesURfS_0NNcQ58130_provenance.
- NP527882.RABShRb7SefYCxrajy81rCKMrfiXjxNesURfS_0NNcQ58130_assertion evidence source_evidence_literature NP527882.RABShRb7SefYCxrajy81rCKMrfiXjxNesURfS_0NNcQ58130_provenance.
- NP527882.RABShRb7SefYCxrajy81rCKMrfiXjxNesURfS_0NNcQ58130_assertion description "[As KRAS mutations are associated with poor response and resistance to EGFR-targeting drugs, this study was conducted to obtain more information on the spectrum of KRAS mutations in ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP527882.RABShRb7SefYCxrajy81rCKMrfiXjxNesURfS_0NNcQ58130_provenance.